Sophisticated computing and human cell cultures are helping minimise animal use in drug development
IMI projects are using advanced computational analysis, human cell lines and tissues, and better models to ‘reduce, replace and refine’ the use of animals in research, writes IMI Executive Director Dr Pierre Meulien in a new opinion piece.
IMI's impact on diabetes: "The best is yet to come" - read the report of our impact series webinarmore
IMI's impact on data: New ways of working - read the report of our impact series webinarmore
IMI's impact on dementia: A radical, end-to-end approach - read the report of our impact series webinarmore
IMI – radical collaboration in action
A new brochure, 'IMI - radical collaboration in action', showcases some recent IMI project successes, which include an approved vaccine for Ebola, insights into the genetics of Alzheimer’s disease, a new classification of diabetes, and advances on using liquid biopsies for cancer, as well as contributions to the fight against COVID-19.
IMI covid-19 response
Within weeks of the first reports of coronavirus in Europe, IMI launched a fast-track Call for proposals to develop therapeutics and diagnostics for current and future coronavirus outbreaks